Search
for
Sort by
Research 361–390 of 488
- 52993 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Pro-inflammatory Vδ1+T-cells infiltrates are present in and around the hair bulbs of non-lesional and lesional alopecia areata hair follicles
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- 320 An open label clinical trial of Abatacept (CTLA4-Ig) for alopecia areata
- Hair follicles as immune targets: unraveling cellular players, cytokine crosstalk, and precision pathways for future therapy of alopecia areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- 185 Regulatory γδ T cells protect human scalp hair follicles from alopecia areata in vivo
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Overview of Alopecia Areata
- Role of janus kinase inhibitors in the treatment of alopecia areata
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- Resident human dermal γδT-cells operate as stress-sentinels: Lessons from the hair follicle
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hair Growth Effect of Emulsion Extracted Brevilin A, a JAK3 Inhibitor, from Centipeda minima
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata
- Interleukin-15 is a hair follicle immune privilege guardian
- Update on pulse corticosteroid therapy for the management of alopecia areata
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy